GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy

Summary

RATIONALE: GSAO may stop the growth of solid tumors by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of GSAO in treating patients with advanced solid tumors that have not responded to therapy.

Timeline

Start

2008-01

Primary completion

2012-04

Completion

2012-04

Outcome

Outcome not reported

Stopped (Business): “Sponsor Decision”

Drugs

Indications